“Post-COVID-19 Pulmonary Fibrosis: The Rationale of Mesenchymal Stem Cell Transplantation for Lung Regeneration”. 2022. Biomedical Research and Therapy 9 (5): 5075-83. https://doi.org/10.15419/bmrat.v9i5.741.